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the conversation and the implications
Introduction
Do you sometimes have a gut feeling? Having a gut wrenching 
experience? If we look superficially at the gut, it is a pretty simple 
structure, a long tube with one hole at each end, and two side 
branches, the billiary and pancreatic ducts.1 Its purpose is intake, 
digestion, absorption, nutrient extraction and excretion.1 However, 
it is smarter and more complex than that. The gut is the only organ 
that contains an intrinsic nervous system with an ability to mediate 
reflexes in the complete absence of input from the brain or spinal 
cord;2 it really does have a mind of its own.
Bi-directional brain-gut interactions play an important role in the 
regulation of many vital functions in health and disease. In health, 
it plays a role in the regulation of digestive processes (including 
appetite and food intake) and in the gut immune system. In disease, 
it causes altered brain-gut interactions which may underlie the 
symptom generation in functional gastrointestinal tract disorders 
(FGIDs), and in the pathophysiology of various eating disorders. 
Routes of communication include: neural, immune system and 
hormonal system.3 The brain-gut axis can be compared with a 
complex reflex circuit of receptors, afferent fibres projecting to the 
integrative central areas and efferent fibres to the effector structures 
(smooth muscle and glands).4
The conversation: levels of neural control
Communication is bi-directional when it comes to the brain (central 
nervous system (CNS) = main frame computer) and the digestive 
system (enteric nervous system (ENS) = iPAD). Neural networks for 
control of digestive functions are positioned in the brain, spinal cord, 
prevertebral sympathetic ganglia and in the walls of specialized 
organs. Control involves an integrated hierarchy of neural centres,2 
which can be divided into 4 levels (Table I).2 
Table I: Levels of neural control2
Level 1 ENS – has local circuitry for integrative functions, 
independent of extrinsic nervous connections
Level 2* Prevertebral sympathetic ganglia - peripheral reflex 
pathways are influenced by preganglionic sympathetic 
fibres from the spinal cord
Levels 3* and 4 Within the CNS
Level 3 Sympathetic and parasympathetic nervous system - 
outflow to the gut is determined, in part, by reflexes 
with sensory fibres that travel with the autonomic 
nervous system
Level 4 Higher brain centres - supply descending signals that 
are integrated with incoming sensory signals at level 3
Effector system Muscles, mucosa and vasculature
*The second and third levels provide input for the integration and action at the fourth level
The central nervous system includes the brain and spinal cord. The 
peripheral nervous system (PNS) is the nerve pathways that extend 
beyond the brain and spinal cord and can be divided into two parts: 
1) somatic nervous system which is responsible for voluntary control 
of muscles and reaction to external sensations and 2) the autonomic 
nervous system (ANS)– responsible for the motor and sensation 
responses of our the viscera (Figure 1).5
Overview of gut innervation
Nerve fibres occur in all the layers of the gastrointestinal tract (GIT). 
GIT viscera receive dual innervation via vagal and spinal primary 
afferents (extrinsic innervation). The GIT also has an intrinsic enteric 
nervous system (ENS), including the intrinsic primary afferent 
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neurons (IPANs), primarily responsible for gut motility and peristalsis.8 
The afferent (sensory) nerve fibres are able to sense information 
about chemical, thermal or mechanical stimuli. Secretion, blood flow 
and contraction are under control of the efferent nerve fibres. They 
even modulate the immune and inflammatory processes within the 
intestine.9-12
Intrinsic innervation
The ENS has about 100 million neurons, which is the largest 
accumulation of nerve cells outside the brain1. It has structural 
and functional similarities to the brain and can be considered as 
the autonomic nervous system of the gut.1 The brain and ENS can 
be compared to a computer network, with the brain being a main 
frame computer and the ENS the laptop or iPAD. The ENS (the iPAD 
of the GIT) is a collection of neurons that constitutes “the brain of 
the gut”.2 It controls motility, regulation of fluid exchange, exocrine 
and endocrine secretions (gastric and pancreatic), defence actions 
of the GIT wall, enteric network reflex activity, neuropeptide release, 
microcirculation of the gut and it is also involved in the response to 
enterotoxins,12,13 and in the regulation of immune and inflammatory 
processes.11 It contains complete reflex circuits that detect the 
physiological condition of the gastrointestinal tract, integrates 
information about the state of the gastrointestinal tract, and controls 
gut movement, fluid exchange between the gut and its lumen, and 
local blood flow.10,12
The  ENS retains communication with the CNS (the main frame 
computer) through parasympathetic and sympathetic afferent and 
efferent neurons.11 The part of the nervous system that is connected 
with the enteric neurons is known as the central autonomic neural 
network.11 Together with these connections, the ENS provides neural 
control of all the functions of the GIT (Figure 2).11
ENS is embedded in the wall of the digestive tract and is basically 
organized into two networks,13 the myenteric plexus (inter-
muscular) and submucosal plexus.1,3,4 The latter, the second brain 
(ENS), is composed of a network of different kinds of neurons, 
neurotransmitters and proteins that carry messages between other 
neurons, interneurons and immune cells. 
The muscles, mucosal epithelium and vascular system are the gut’s 
effector systems. The behaviour of the gut, at any given moment, 
reflects integrated neural activity of these effector systems.2 The 
ENS is a mini brain (iPAD) on which a library of programmes for 
different patterns of behaviour is loaded.2 Digestive, interdigestive 
and emetic patterns of intestinal behaviour reflect outputs from 
these three respective programmes (documents produced by the 
iPAD).2 
Central nervous system (CNS)
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Peripheral nervous system
Cranial and spinal nerves
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Figure 1: Gut innervation6,7 
Figure 2: Brain-gut interaction11 
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Approximately 20 types of enteric neurons are divided into 
three classes according to their functions: intrinsic primary 
afferent neurons (IPANs), also referred to as intrinsic sensory 
neurons, interneurons and motor neurons.2,12
The gastrointestinal tract also has an extensive endocrine signalling 
system, and many gastrointestinal functions are under dual neuronal 
and endocrine control.12 Enteric neurons interact with the extensive 
intrinsic immune system of the gastrointestinal tract. Enteric neurons 
secrete a large number of neurotransmitters (Table II).11 In fact, 95% 
of the body’s serotonin is found in the ENS, along with the major cells 
of the immune system’s inflammatory network.3,14-16 Neuropeptides, 
once believed to exist exclusively in the central nervous system 
are also found in the gut.11 The existence of neuropeptides such as 
serotonin and endorphins, that impact on emotions and thinking, 
in the gut, suggests that it has the ability to think and feel; “gut-
feelings” may thus be a physical phenomenon.
Enteroenteric reflexes
Signals between gut regions are carried both by hormones [such as 
cholecystokinin (CKK), gastrin and secretin] and by nerve circuits.8
Neuroimmune interactions
Two-way communication (another two way street) occurs between 
the enteric nervous system and the immune system of the 
gastrointestinal tract, that is, transmitters released by the terminals 
of enteric neurons in the mucosa influence immune-related cells, 
such as mast cells (MC), and the cells of the mucosa release active 
substances, including cytokines and mast cell tryptase, that act 
on enteric neurons.17,18 The inter-communication that occurs in 
disorders such as IBS is briefly discussed later in this article. 
Extrinsic innervation
The ENS is well connected to the central autonomic network in the 
CNS through both motor and sensory pathways of the sympathetic 
and parasympathetic nervous system (Figure 2).4,11 The information 
collected by receptors is transmitted via autonomic fibres.4
In addition, the gastrointestinal tract receives a dual extrinsic 
innervation. The efferent nerves which can be sympathetic and/or 
parasympathetic fibres that modulate motor and secretory patterns 
programmed in the enteric nervous system. Sympathetic fibres are 
also important in regulating blood flow. The extrinsic afferents (i.e. 
sensory nerves) generally travel together with these efferents and 
they carry information about visceral stimuli to the brain.19 
Sensory output from the gut to the CNS
The receptors of the gut are mostly specialized afferent neural 
terminations capable of directly collecting sensory information 
(chemical, mechanical, thermal and pain)4 and carries it via the 
vagal and splanchnic nerves to the brain.9 Primary afferents in the 
smooth muscle layer are sensitive to mechanical distension of the 
gut. They have a very low threshold and convey information about 
physiological motor activities in the gut.11 Most of this information 
will never reach consciousness, and they are responsible for the 
fullness, nausea, discomfort and pain we perceive. The afferents can 
be activated by mechanosensitivity, chemosensitivity, sensory signal 
transduction and promiscuous chemosensitivity. 9,20
Mechanosensitivity
Nerve terminals convey mechanosensory information relevant 
to distention and contraction of the bowel wall.9 However, the 
information generated at these sites and conveyed by vagal 
and spinal mechanosensitive afferents is very different.9 It is 
hypothesized that vagal afferents are involved in physiological 
regulation while spinal afferents are responsible for mediating pain 
in diseases such as IBS.9,20 Mechanosensitivity can be influenced by 
a wide range of chemical mediators released as a consequence of 
injury or inflammation.9,20
Chemosensitivity
Many chemical mediators are able to influence the sensitivity 
of visceral afferents.20 Splanchnic primary afferent neurons are 
Table II: Neurotransmitters in the ENS11 (used with permission of the 
authors)
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nociceptors, responding to high intensity stimuli, and are involved 
in sensing pain in the gastrointestinal tract.11 These mediators can 
influence the visceral afferents through three processes: direct 
activation, sensitization and through altering the phenotype of the 
afferent nerve.20 Neurotransmitters, such as calcitonin gene–related 
peptide and substance P may be important in visceral nociception 
and in the activation of nociceptive afferent neurons in conditions 
such as irritable bowel syndrome, as well as noncardiac chest pain, 
intestinal ischaemia, and inflammatory bowel disease.11
Sensory signal transduction
Some mediators produce a direct stimulation of visceral sensory 
nerve endings.20 In this case, the afferent neurons do not respond 
directly to a stimulus, but after the release of a mediator from a 
primary sense cell.20 Cells that act as primary signal transducers 
include enterochromaffin (EC) cells which release serotonin (5-HT) 
and the enteroendocrine cells that release CCK20 both of which 
are thought to play a role in the pathophysiology of IBS. In order 
to bridge the large gap between ECs and their targets, a massive 
amount of neurotransmitter is released, which makes transmitter 
removal mechanisms critical. The ECs are particularly important in 
GIT motility and IBS through 5-HT’s role in signal transduction which 
initiates peristaltic and secretory reflexes. An overflow of 5-HT into 
the GIT lumen and portal circulation are thought to play a role in IBS 
pathophysiology.21
Promiscuous chemosensitivity
In contrast to the specific signalling pathways that exist in vagal 
mucosa afferents, there are also mediators that can influence the 
sensitivity of spinal afferents in a more promiscuous manner.20 
Various cells types (macrophages, MCs, muscle and neurons) can 
release these substances under conditions of inflammation, injury 
or ischaemia.20 Although some substances act directly on sensory 
nerve terminals, other substances acts indirectly, through a series 
of cascades.20
The implications: irritable bowel disease
Malfunction in the brain-gut axis plays a role in satiety, obesity, 
glucose control and various FGIDs such as irritable bowel disease 
(IBS). 
IBS is a multidimensional symptom complex characterized by 
abdominal pain and discomfort, bloatedness and altered bowel 
habits.16,22 In addition, there is a substantial psychological co-morbidity 
in many patients, frequent with extra-intestinal manifestations.16 IBS 
is affected and modulated by many factors related to emotional 
factors, visceral function and sensation. The symptoms associated 
with IBS can be best explained as a dysregulation between the 
complex events occurring in the gut lumen, the mucosa, the ENS 
and the CNS, which results in alterations in sensation, motility and 
immune function.3
Abnormal motility
Although initially considered the main pathophysiological cause of 
IBS, consistent motility abnormalities have not been demonstrated 
in all IBS patients.14 Dysmotility in the gut can develop through 
dysfunction in any level in the brain-gut axis.23 Stress causes 
a release of central corticotrophin-releasing factor (CRF) which 
accelerates colonic transit and defaecation through stimulation 
of vagal efferents.22,24 Inflammatory mediators, neuropeptides 
and other processes may directly affect muscle function or other 
elements in the ENS.24,26
Visceral hypersensitivity
Abdominal pain, tenderness and visceral hypersensitivity are 
common symptoms in IBS, but the exact site of the disordered 
neurophysiology is not known.14,23,25 There are several possible 
locations for the sensory abnormalities in IBS such as the receptors 
in the gut wall, the primary sensory afferent neurons, the spinal cord 
and the brain itself.26 In addition, descending inhibitory mechanisms 
for the control of visceral signal transmission may be altered.22 
A lower threshold to discomfort and the threshold to pain during 
balloon distension is again a common, but not a universal, finding 
in patients with IBS.14,23,25 Visceral hypersensitivity involves both 
the peripheral and central nervous system.22 Afferents carry the 
message from the gut to the brain where pain is perceived and it 
can be amplified in the gut, spinal cord or the brain resulting in an 
increase in brain response.22 Mechanosensitive afferents may be 
hypersensitive to noxious stimuli and transmit erroneous information 
to the central nervous system. On the other hand, the information 
may be accurate but misinterpreted by central processing circuits 
responsible for visceral nociception. In some patients, derangements 
may exist in both brain and periphery.27
Many patients report postprandial worsening of symptoms. 
Enhanced colonic sensitivity has been demonstrated in IBS patients 
after duodenal lipid administration,25 suggesting an exaggerated 
sensory component of the gastrocolonic response.25 5-HT3 receptor 
stimulation by serotonin seems to be directly related to visceral 
nociception in rodents, thus serotonin may modulate nociception.27
Central nervous system modulation
Results from a recent meta-analysis documented that colonic 
stimulation causes a consistent activation in regions associated 
with visceral afferent processing (i.e. thalamus, insula, anterior 
midcingulate) in both controls and IBS patients, but there is 
considerable differences in specific location of foci. IBS patients 
showed more consistent activation in regions associated with 
emotional arousal (pregenual anterior cingulated cortex, amygdale 
and a mid-brain cluster) and cognitive processing of sensory input 
and endogenous pain modulation.28 Reduced activation was noticed 
in the perigenual cortex, temporal lobe and brain stem.27 This 
data does not necessarily indicate a central aetiology for visceral 
hypersensitivity, but may indicate a normal cerebral response to 
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heightened incoming sensory signals.23 IBS patients seem to fail 
to use central nervous system down-regulating mechanisms in 
response to incoming or anticipated visceral pain.14 
Autonomic dysfunction has also been reported in IBS, but the 
results are inconsistent. Increased sympathetic and decreased 
parasympathetic activity in IBS patients compared to control is the 
most common abnormalities reported.23 
Stress
Stress has always been considered as part of the pathophysiology 
of IBS. It has been postulated that sustained stress (central or 
peripheral; in predisposed individuals) can result in permanent pain 
increase stress responsiveness of the central stress circuits and 
eventually result in a vulnerability to develop functional and affective 
disorders. Stress is strongly associated with the onset, exacerbation 
and severity of IBS symptoms. In addition, IBS patients report more 
lifetime and daily stressful events compared to healthy individuals. 
Normal people also exhibit gut function abnormalities during stress 
such as butterflies in the stomach before a game of sport. However, 
it would appear that IBS patients have a greater reactivity to stress 
than healthy individuals.14 It is also of note that IBS patients often have 
concurrent psychological disturbances. A proposed model in terms 
of stress and IBS suggests that adverse events (past or present) can 
influence stress responsiveness, physiological responses as well 
as the susceptibility to developing and exacerbating this functional 
disorder through amplification of brain-gut interactions.14
Recent data suggest a dysregulation of adrenal activity in IBS 
patients. IBS patients, compared to controls, showed increased 
salivary cortisol levels in the morning, while they maintained the 
physiological circadian fluctuations.27 Stressors (physical and 
psychological) can activate the hypothalamic-pituitary adrenal axis 
(HPA) as well as the sympatho-adrenomedullary system22,29 resulting 
in central release of CRF and consequently glucocorticoid secretion 
by the adrenal cortex into the circulatory system. 22 Cortisone affects, 
amongst others, immune response, metabolic actions and motility 
in IBS.22,29 
In response to distension, central CRF can cause peripheral 
activation of MCs, sensitizing of the mechanoreceptors or promotion 
of MC degranulation in the gut. In addition CRF can be synthesized 
in colonic mucosa cells and the local release can modulate the 
enteric immune system and other gut functions. CRF signalling also 
promotes immune response and stimulates lymphocyte proliferation 
through IL-2 receptor expression, which in turn enhances IL-1 and 
IL-2 production. CRF plays a role in endotoxin induced cytokine 
release, chemotaxis of mononuclear cells, induction of macrophage 
activation leading to local release of oxidative mediators and 
proinflammatory cytokines.22
 The HPA axis may play a role in non-standard immune activation in 
the gut wall. This is represented by an abnormal mucosal response 
to altered microbiota such as increased infiltration of mast cells, 
enteroendocrine cells and mononuclear cells in the colonic mucosa, 
without frank inflammation.29
Research focusing on the role of anxiety in the exacerbation of IBS 
symptoms investigated the role of the limbic system and mainly that 
of the amygdaloid nucleus in visceral responses to stress. It would 
appear that descending neural pathways from the amygdale are 
involved in the viscemotor response, mediated by CRF-1 receptors 
which are responsible for colonic and anxiogenic responses to 
stress. Endogenous serotonin peripherally released in response to 
stress is probably involved in central CRF-induced stimulation of 
colonic motility by acting in 5HT
3 receptors. CRF receptors are also 
located peripherally on enteric smooth muscle and can be stimulated 
by locally produced CRF, by enteric neurons, ECs and immune cells.27
Immune or inflammatory mediators
The neuro-immune axis may also play a role in IBS pathophysiology.23 
Various mediators are released during the inflammatory response 
that have the ability to induce changes in visceral perception, 
secretion and motility. Transient or chronic (possibly low grade) 
inflammation may play an important role in IBS pathogenesis.22,26 
A subset of IBS patients reports the onset of IBS symptoms after 
infectious gastroenteritis and it is referred to as post-infectious IBS 
(PI-IBS).14,16 A PI-IBS model may be a good example of brain and gut 
interaction. Anxiety and depression have been found to be signif-
icant and independent risk factors of PI-IBS.30
Various abnormalities have been documented in terms of increased 
activation of and infiltration by immune mediators and cells, providing 
evidence for an intense local immune response.14,22,23,26,31 In PI-IBS 
there is consistent evidence in many patients of increased presence 
of EC in the colon and enteroendocrine cells in the rectum.26,29 
Therefore, there is the possibility that increased release of serotonin 
(5-HT) may contribute to the chronic diarrhoea.16 IBS patients may 
have a relative deficiency of anti-inflammatory cytokines and/or an 
increased expression of proinflammatory cytokines.23
It has been postulated that a defect in the ENS plays a major role 
in IBS, possibly through neurotransmitters, such as serotonin and 
substance P, which can cause the symptoms in IBS.22 Activated 
lymphocytes and macrophages release various mediators, including 
nitric oxide, interleukin, histamine and protease which can stimulate 
the ENS and eventually result in abnormal secretion and motor 
response in the gut.22 The consequent release of cytokines and other 
inflammatory mediators causes tissue damage which contributes to 
the characteristics of IBS pain. Cytokines regulate and coordinate the 
immune response, but also play an important role in the development 
of visceral pain and anxiety or depression as well as motor dysfunction, 
mediated by the CNS29 and it also amplifies and perpetuates the local 
immune response.22 These inflammatory mediators may thus play a 
role in the pathophysiology of IBS, mainly through interactions in the 
brain-gut-axis.14 The specific role of cytokines in IBS has not been 
fully elucidated. Significant symptomatic relief has been found with 
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administration of the probiotic Bifidibacterium infantis 35624 and 
may be related to the normalization of the cytokine ratio. Although 
some changes in chemokines have been reported, their role in IBS is 
not fully understood.29
The fact that percentage of colonic mucosa infiltrated by immune 
cells in IBS was between the extremes of healthy and true 
inflammation as in IBD, may indicate a common physiological factor 
triggering these disorders. Thus IBS and IBD may represent two ends 
of a wide spectrum of chronic inflammatory disorders.29 
MC nerve interactions are involved in intestinal epithelial dysfunction 
and the development of stress-induced increase of colonic 
permeability.22 The continued activation of MC could contribute to 
the motility dysfunction, and be due to their proximity to neurons in 
the ENS, also to the visceral hypersensitivity in PI–IBS.23,29,32 Many, 
but not all, studies found increased numbers of MC in patients 
with IBS, but increased numbers of MC does not necessarily imply 
pathology, unless there are activated.22,32 Increased number of 
degranulating MC has been demonstrated in IBS patients22,33 and has 
been correlated with the severity and frequency of abdominal pain, 
bloating and is possibly with rectal hypersensitivity.22,29 The MC may 
also be involved in the communication with intrinsic and extrinsic 
nerves to modulate sensory functioning.29 Release of mediators from 
the MC include responses in the ENS such as visceral hyperalgesia 
and increased mucosal permeability, as well as the generation of 
symptoms such as abdominal pain and bowel habit.29
Neuropeptides
Neuropeptides plays a role in the regulation of gut motility and 
secretion3 and appear to modulate sensitivity.
Serotonin
Serotonin, a biogenic amine, is predominantly located in the 
gastrointestinal tract.3 Ninety-five per cent of serotonin is found 
in the GIT of which 90% is localized in the EC and 10% in enteric 
neurons3,14-16,27 and enteric MCs.27 Serotonin is released by signalling 
functions in the enteric nervous system.27
Serotonin is involved at just about every level of the bi-directional 
communication between gut and brain. Recent studies have 
implicated alterations in serotonin (5-hydroxytryptamine, 5-HT) 
signalling in FGIDs, such as the IBS, chronic constipation, diarrhoea, 
and functional dyspepsia. GIT disorders may be related to an 
imbalance of serotonin in the gut or a variant reaction of the GIT to 
serotonin or a faulty communication network between serotonin in 
the gut and the brain and spinal cord.15
Serotonin can be released from enterocytes and ECs in response to 
chemical or mechanical stimulation and to experimental stressors.5 
There are seven distinct families of 5-HT receptors, but two (5-HT3 
and 5-HT4) predominate in the gut.
27 Although 5-HT3 receptors are 
located on enteric nerves within the myenteric plexus as well as on 
vagal and spinal afferents, it can also be found in the brain, spinal 
cord and dorsal root ganglion neurons.4,15,27 Serotonin is an important 
mediator of peristaltic reflex14 and activation of 5-HT3 receptors is 
associated with enhanced GI motility, secretion, and sensation.15 
The more potent effect of the 5-HT3 receptor is to activate extrinsic 
nerves of the gut.3
There is evidence of enhanced postprandial serotonin release in IBS 
patients.27 A recent study showed increased serotonin concentration 
in colonic mucosa of patients with constipation predominant IBS 
(C-IBS) compared to those with diarrhoea predominant IBS (D-IBS).27 
IBS-C and IBS-D differ in terms of both number of EC and 5-HT 
release in most, but not all,34,35 studies.16,36,37 Both 5-HT release and 
EC cell population in the gut is increased in patients with IBS-D,14,16,37 
whereas in some subgroups of patients with chronic constipation, 
there appears to be a decreased number of EC cells,14,36,37 
suggesting that stimulation of the serotoninergic pathways may 
improve symptoms in these patients.14,16 Altered EC cells and/or 
5-HT signalling can result in gastrointestinal dysmotility, visceral 
hypersensitivity, and secretomotor abnormalities. The body is able 
to regulate the availability of serotonin within the extracellular space 
through serotonin reuptake transporter (SERT).14 The efficacy of 
5-HT3 receptor blockade in women with diarrhoea predominant IBS 
suggests an over-stimulation of secretomotor neurons by serotonin. 
Various other mediators and transmitters are involved in the 
regulation of colonic motility and visceral perception such as 
calcitonin gene related peptide, substance P, nor-epinephrine and 
opiates but their role remains to be elucidated.27
Microbiota
Research is emerging showing the possible role of the gut microbiota 
in IBS, particular their role in the brain-gut axis conversation. 
Dysbiosis, including small bowel bacterial overgrowth, alterations in 
the quantity of microbiota as well as the composition of the microbiota 
is well documented in IBS as well as the role of infections and 
antibiotics in the pathophysiology of IBS.38 Although the mechanisms 
are not yet fully elucidated, it is known that the microbiota plays 
a role in the maintenance and function of intestinal epithelial cells 
which plays a central role in intestinal immunity. Evidence is also 
emerging for the role of the presence of inflammatory and immune 
components in IBS. In addition, supplementation with probiotics can 
alter the luminal environment or microbiota composition of the gut. 
Interaction between the host and the microbiota plays an important 
role in nociception as well as gut motility.9 Psychological stress has 
been shown to reduce the numbers of Lactobacilli and increase the 
growth of pathogens.39 The microbiota is able to affect sensorimotor 
functions of the gut in three ways through end products of bacterial 
fermentation and metabolism, neuroendocrine factors and immune 
mediators.40
The unravelling of the complexity of the brain-gut communication is 
beginning to afford a better understanding of the pathophysiology 
of IBS and further research is likely to lead to its more specific 
treatment. 
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